70 related articles for article (PubMed ID: 8861708)
1. Dilazep inhibits binding of batrachotoxin to sodium channels in canine sarcolemmal vesicles.
Chiba K; Hashizume H; Inagaki SI; Abiko Y
Arch Int Pharmacodyn Ther; 1995; 330(2):138-50. PubMed ID: 8861708
[TBL] [Abstract][Full Text] [Related]
2. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
Hill RJ; Duff HJ; Sheldon RS
Mol Pharmacol; 1989 Jul; 36(1):150-9. PubMed ID: 2546048
[TBL] [Abstract][Full Text] [Related]
3. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
Sheldon RS; Duff HJ; Thakore E; Hill RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):187-94. PubMed ID: 8301556
[TBL] [Abstract][Full Text] [Related]
4. A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels.
Sheldon RS; Cannon NJ; Duff HJ
Circ Res; 1987 Oct; 61(4):492-7. PubMed ID: 2443266
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel.
Sheldon RS; Hill RJ; Cannon NJ; Duff HJ
Circ Res; 1989 Aug; 65(2):477-82. PubMed ID: 2546697
[TBL] [Abstract][Full Text] [Related]
6. Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor.
Hill RJ; Thakore E; Taouis M; Duff HJ; Sheldon RS
Eur J Pharmacol; 1991 Oct; 203(1):51-8. PubMed ID: 1665791
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytes.
Taouis M; Sheldon RS; Hill RJ; Duff HJ
J Biol Chem; 1991 Jun; 266(16):10300-4. PubMed ID: 1645346
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
Postma SW; Catterall WA
Mol Pharmacol; 1984 Mar; 25(2):219-27. PubMed ID: 6321944
[TBL] [Abstract][Full Text] [Related]
9. Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n - 3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes.
Kang JX; Li Y; Leaf A
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2724-8. PubMed ID: 9122264
[TBL] [Abstract][Full Text] [Related]
10. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
Hill RJ; Duff HJ; Sheldon RS
Mol Pharmacol; 1988 Nov; 34(5):659-63. PubMed ID: 2848186
[TBL] [Abstract][Full Text] [Related]
11. Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins.
Kang JX; Leaf A
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3542-6. PubMed ID: 8622972
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug.
Taouis M; Sheldon RS; Duff HJ
J Clin Invest; 1991 Aug; 88(2):375-8. PubMed ID: 1650791
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific interaction of tocainide with the cardiac sodium channel.
Sheldon RS; Cannon NJ; Nies AS; Duff HJ
Mol Pharmacol; 1988 Mar; 33(3):327-31. PubMed ID: 2451117
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by propofol of [3H]-batrachotoxinin-A 20-alpha-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes.
Ratnakumari L; Hemmings HC
Br J Pharmacol; 1996 Dec; 119(7):1498-504. PubMed ID: 8968561
[TBL] [Abstract][Full Text] [Related]
15. Modulation of flecainide's cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity.
Ranger S; Sheldon R; Fermini B; Nattel S
J Pharmacol Exp Ther; 1993 Mar; 264(3):1160-7. PubMed ID: 8383739
[TBL] [Abstract][Full Text] [Related]
16. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
Sheldon RS; Cannon NJ; Duff HJ
Mol Pharmacol; 1986 Dec; 30(6):617-23. PubMed ID: 2431264
[TBL] [Abstract][Full Text] [Related]
17. Activation of sodium channels and inhibition of [3H]batrachotoxinin A-20-alpha-benzoate binding by an N-alkylamide neurotoxin.
Ottea JA; Payne GT; Bloomquist JR; Soderlund DM
Mol Pharmacol; 1989 Aug; 36(2):280-4. PubMed ID: 2549384
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.
Thomsen W; Hays SJ; Hicks JL; Schwarz RD; Catterall WA
Mol Pharmacol; 1993 Jun; 43(6):955-64. PubMed ID: 8391120
[TBL] [Abstract][Full Text] [Related]
19. Kavain, dihydrokavain, and dihydromethysticin non-competitively inhibit the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels.
Friese J; Gleitz J
Planta Med; 1998 Jun; 64(5):458-9. PubMed ID: 9690349
[TBL] [Abstract][Full Text] [Related]
20. Natural products from ginseng inhibit [3H]batrachotoxinin A 20-alpha-benzoate binding to Na+ channels in mammalian brain.
Duan Y; Zheng J; Law V; Nicholson R
Eur J Pharmacol; 2006 Jan; 530(1-2):9-14. PubMed ID: 16359658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
